Laboratory assessment of rivaroxaban: a review

Research into new anticoagulants for preventing and treating thromboembolic disorders has focused on targeting single enzymes in the coagulation cascade, particularly Factor Xa and thrombin, inhibition of which greatly decreases thrombin generation. Based on the results of phase III clinical trials,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Samama, Meyer Michel, Contant, Geneviève, Spiro, Theodore E, Perzborn, Elisabeth, Le Flem, Lena, Guinet, Céline, Gourmelin, Yves, Rohde, Gabriele, Martinoli, Jean-Luc
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3726412/
https://ncbi.nlm.nih.gov/pubmed/23822763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-9560-11-11
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky